Preparation and purification method of adipose tissue-derived stromal cell exosome

Through the special monoclonal antibody-coupled magnetic beads combined with ultracentrifugal separation step, the problem of expensive equipment and complex operation in the preparation method of fat mesenchymal stem cell exosomes is solved, and efficient and low-cost high-purity exosome preparation is achieved. , suitable for the treatment of diabetes wound repair.

CN118995589APending Publication Date: 2024-11-22GUANGZHOU JINGJIE BIOTECHNOLOGY CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411132150.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-19
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The existing preparation methods for fat mesenchymal stem cell exosomes are expensive, complex, long-term and cumbersome, and it is difficult to meet the needs of high efficiency, low cost and high purity.

Method used

Immunoaffinity capture and purification was performed using monoclonal antibody-conjugated magnetic beads that specifically bind Nrf2 protein and CD63 protein, combined with ultracentrifugation separation steps, simplifying the operation process and improving exosome yield and purity.

Benefits of technology

Effectively improve the yield and purity of exosomes of fat mesenchymal stem cells, reduce production costs, simplify the operation process, and ensure the biological activity and functional integrity of exosomes. It is suitable for large-scale production and diabetes wound repair treat.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995589A_ABST
    Figure CN118995589A_ABST
Patent Text Reader

Abstract

The invention discloses a magnetic bead for immunoaffinity capture of an adipose tissue-derived stem cell exosome. The magnetic bead is coupled with a monoclonal antibody 1 which is specifically combined with Nrf2 protein and a monoclonal antibody 2 which is specifically combined with CD63 protein; wherein the amino acid sequences of a heavy chain variable region and a light chain variable region of the monoclonal antibody 1 are respectively shown as SEQ ID NO.1 and SEQ ID NO.2. The invention also discloses a preparation and purification method of the adipose-derived stem cell exosome, and the method comprises the following steps: (1) culture of adipose-derived stem cells: resuscitation of adipose-derived stem cells, subculture of adipose-derived stem cells and treatment of adipose-derived stem cell exosome-free culture medium; and (2) separating and purifying the adipose-derived stem cell exosome, namely collecting adipose-derived stem cell culture supernatant, separating and purifying the exosome through ultracentrifugation, and capturing and purifying the exosome through immunoaffinity. The prepared exosome has good performance and has a good treatment effect on skin wounds caused by diabetes mellitus.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biotechnology, and in particular to a method for preparing and purifying adipose-derived mesenchymal stem cell exosomes. Background Art

[0002] Exosomes of adipose-derived mesenchymal stem cells (ADSCs) have been a hot topic in the field of regenerative medicine in recent years, showing great potential in tissue repair and immune regulation. Exosomes are important mediators of intercellular communication, carrying biomolecules such as proteins, lipids, and RNA, which can affect the function of receptor cells.

[0003] At present, there are various methods for preparing exosomes, including ultrafiltration, kit precipitation, sucrose gradient centrifugation, ultracentrifugation, etc. Each method has its advantages and disadvantages. For example, ultracentrifugation removes impurities through multiple differential centrifugation steps to obtain high-purity exosomes. Although the exosomes obtained by this method have the highest purity and are suitable for high-quality research and clinical applications, the equipment is expensive, the operation is complicated and time-consuming. Density gradient centrifugation is to construct a gradient using dense materials such as sucrose, and the exosomes are separated by centrifugation to sediment to a specific layer. Although this method can effectively remove impurities and obtain exosomes of higher purity, its operation process is relatively cumbersome and requires precise control of the density gradient and centrifugation conditions.

[0004] Therefore, it is necessary to develop a method with better comprehensive performance based on the existing methods for the preparation and purification of adipose-derived mesenchymal stem cell exosomes. Summary of the invention

[0005] In order to make up for the deficiencies of the prior art, the object of the present invention is to provide a method for preparing and purifying adipose-derived mesenchymal stem cell exosomes.

[0006] Therefore, on one hand, the present invention discloses a magnetic bead for immunoaffinity capture of adipose-derived mesenchymal stem cell exosomes, wherein the magnetic bead is coupled with a monoclonal antibody 1 that specifically binds to the Nrf2 protein and a monoclonal antibody 2 that specifically binds to the CD63 protein; wherein the amino acid sequences of the heavy chain variable region and the light chain variable region of the monoclonal antibody 1 are shown in SEQ ID NO.1 and SEQ ID NO.2, respectively.

[0007] Preferably, the amino acid sequences of the heavy chain variable region and the light chain variable region of the monoclonal antibody 2 that specifically binds to the CD63 protein of the present invention are shown as SEQ ID NO.3 and SEQ ID NO.4, respectively.

[0008] In another aspect, the present invention further discloses a method for preparing and purifying adipose-derived mesenchymal stem cell exosomes, the method comprising the following steps:

[0009] (1) Adipose-derived stem cell culture, including adipose-derived stem cell recovery, adipose-derived stem cell subculture, and adipose-derived stem cell exosome-free culture medium treatment;

[0010] (2) Isolation and purification of exosomes from adipose-derived stem cells, comprising: collecting the supernatant of adipose-derived stem cell culture, separating and purifying exosomes by ultracentrifugation, and purifying exosomes by immunoaffinity capture, wherein the immunoaffinity capture of purified exosomes is performed by using the magnetic beads prepared according to claim 1 to screen exosomes that highly express Nrf2 protein and CD63 protein from exosomes separated and purified by ultracentrifugation.

[0011] Preferably, the collection of the adipose stem cell culture supernatant in step (2) of the present invention comprises the following steps: collecting the cell culture supernatant after 24 hours of culture, centrifuging at 1000 rpm for 10 minutes to remove cell debris; after passing the supernatant through a 0.22 μm filter membrane, transferring it to a 100KD ultrafiltration tube, and centrifuging it at 4°C 4000 rpm for 30 minutes to obtain a concentrated solution containing exosomes; centrifuging the concentrated solution containing exosomes at 4°C 10000 g for 30 minutes to further remove apoptotic bodies.

[0012] Preferably, the ultracentrifugation separation and purification of exosomes in step (2) of the present invention comprises the following steps: transferring the prepared exosome-containing concentrated solution to an ultracentrifuge tube, centrifuging at 100,000 g at 4°C for 70 minutes, and the precipitate is the exosome; carefully discarding the supernatant, resuspending the precipitate with an appropriate amount of PBS, and then centrifuging at 100,000 g for 70 minutes; carefully discarding the supernatant, resuspending the precipitate with an appropriate amount of PBS, and then centrifuging at 100,000 g for 70 minutes, which is the collected exosomes.

[0013] Preferably, the immunoaffinity capture and purification of exosomes in step (2) of the present invention comprises the following steps: taking 1 ml of the collected exosomes, adding them to 1 ml of magnetic beads, and after mixing evenly, rotating and incubating at room temperature for 1 hour to allow the antibody to fully bind to the exosomes; transferring the sample to a magnetic rack, separating the magnetic beads with antibodies, and aspirating the supernatant; washing the exosomes on the magnetic beads three times with a washing buffer; adding 1 ml of PBS buffer each time, rotating and mixing for 5 minutes, separating the magnetic beads with a magnetic rack, and discarding the supernatant; adding 0.2 ml of elution buffer, rotating and mixing for 5 minutes, repeating three times, collecting the eluate, and then dialyzing against PBS at 4°C overnight to obtain specific exosomes. The obtained specific exosomes are filtered using 0.22 μm and stored at -80°C for later use.

[0014] In another aspect, the present invention further discloses a use of the monoclonal antibody 1 that specifically binds to the Nrf2 protein in the preparation of adipose-derived mesenchymal stem cell exosome immunoaffinity capture magnetic beads.

[0015] In another aspect, the present invention also discloses a use of the monoclonal antibody 2 that specifically binds to CD63 protein in the preparation of adipose-derived mesenchymal stem cell exosome immunoaffinity capture magnetic beads.

[0016] The present invention can effectively improve the yield and purity of adipose-derived mesenchymal stem cell exosomes, reduce production costs, simplify the operation process, and ensure the biological activity and functional integrity of exosomes. The exosome preparation and purification method provided by the present invention is suitable for large-scale production and has wide application potential.

[0017] In addition, the exosomes 2 prepared by the method of the present invention have a good therapeutic effect on the wound repair caused by diabetes. Therefore, the present invention provides a good reference for the preparation method of exosomes in the wound repair caused by diabetes.

[0018] Furthermore, in order to purify exosomes 2 from exosomes 1, the present invention prepared monoclonal antibody 1 that specifically binds to Nrf2 protein and monoclonal antibody 2 that specifically binds to CD63 protein, which have good sensitivity and specificity, and provide a good tool and reference for further purification of exosomes! BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 Exosome TEM detection results (100nm).

[0020] Figure 2 Schematic diagram of the monoclonal antibody preparation process.

[0021] Figure 3 The therapeutic effects of exosomes on skin wounds induced by high glucose. DETAILED DESCRIPTION

[0022] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those generally understood by those skilled in the art of the present invention. The terms used herein in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The term "and / or" used herein includes any and all combinations of one or more related listed items.

[0023] Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art. The culture medium used for the isolation and culture of human mesenchymal stem cells was purchased from Merck. Unless otherwise specified, the reagents and materials used in the following examples were commercially available.

[0024] Example 1: Preparation of adipose-derived mesenchymal stem cell exosomes

[0025] 1 Cell culture

[0026] 1.1 Recovery of adipose-derived stem cells (ADSCs) (self-isolation and identification or commercial purchase, for self-isolation and identification, please refer to the literature: Wang Jing, Cai Xia, Wang Zhiguo, Xu Quanchen, Li Kun, Hua Cheng. Isolation and identification of exosomes derived from human adipose-derived mesenchymal stem cells [J]. Chinese Journal of Tissue Engineering Research, 2019, 23(17): 2651-2658. DOI: 10.3969 / j.issn.2095-4344.1715)

[0027] The frozen ADSCs cells were quickly thawed in a 37°C water bath, 5 ml of DMEM / F12 medium containing 10% FBS was added, mixed and centrifuged at 800 rpm for 5 minutes, and then resuspended in 5 ml of DMEM / F12 medium containing 10% FBS and transferred to a 25 cm 2 The cells were placed in a culture flask and cultured in a 37°C incubator containing 5% CO2. When the cells grew to a confluence of about 80%, the cells were passaged.

[0028] 1.2 Subculture of adipose-derived stem cells

[0029] Wash the cells twice with PBS, add 0.25% trypsin, and place in a 37°C incubator for digestion for 2-3 minutes. Add an appropriate amount of 10% FBSDMEM / F12 medium to terminate digestion, and gently blow the cells to disperse them. Subculture the cells at a ratio of 1:3-1:5 and culture them in a 37°C incubator containing 5% CO2.

[0030] 1.3 Treatment of adipose-derived stem cells with exosome-free culture medium

[0031] When the cell confluence reaches 70-80%, serum-free DMEM / F12 medium is used. After culturing for 24 hours, exosomes can be collected.

[0032] 2 Isolation and purification of exosomes from adipose-derived stem cells

[0033] 2.1 Collection of adipose-derived stem cell culture supernatant

[0034] The cell culture supernatant was collected after 24 hours of culture and centrifuged at 1000 rpm for 10 minutes to remove cell debris. The supernatant was filtered through a 0.22 μm filter membrane and transferred to a 100KD ultrafiltration tube. It was centrifuged at 4000 rpm for 30 minutes at 4°C to obtain a concentrated solution containing exosomes. The concentrated solution containing exosomes was centrifuged at 10000 g at 4°C for 30 minutes to further remove apoptotic bodies.

[0035] 2.2 Ultracentrifugation separation and purification of exosomes

[0036] Transfer the concentrate to an ultracentrifuge tube and centrifuge at 100,000 g for 70 minutes at 4°C. The precipitate is the exosome. Carefully discard the supernatant, resuspend the precipitate with an appropriate amount of PBS, and centrifuge again at 100,000 g for 70 minutes. Carefully discard the supernatant, resuspend the precipitate with an appropriate amount of PBS, and the collected exosomes are recorded as exosomes 1. The exosomes 1 collected in this step can be stored at -80°C for future use and can generally be stored for 12 months.

[0037] 2.3 Immunoaffinity capture and purification of exosomes

[0038] Take 1ml of the collected exosomes and add them to 1ml of magnetic beads (prepared in Example 3 of the present invention) labeled with Nrf2 protein monoclonal antibody and CD63 monoclonal antibody to mix. After mixing evenly, rotate and incubate at room temperature for 1 hour to allow the antibody to fully bind to the exosomes. Transfer the sample to a magnetic stand, separate the magnetic beads with antibodies, and aspirate the supernatant. Use the washing buffer to wash the exosomes on the magnetic beads 3 times; add 1ml PBS buffer each time, rotate and mix for 5min, then use the magnetic stand to separate the magnetic beads, and discard the supernatant. Add 0.2ml elution buffer (generally PBS buffer containing 0.5mM β-mercaptoethanol), rotate and mix for 5min, repeat 3 times, collect the eluate, and then dialyze PBS at 4°C overnight to obtain specific exosomes. The obtained specific exosomes are filtered using 0.22μm and recorded as exosomes 2. Exosomes 2 collected in this step can be stored at -80°C for standby use, and can generally be stored for 12 months.

[0039] Example 2: Detection of exosomes from adipose-derived mesenchymal stem cells

[0040] 2.1 Transmission electron microscopy (TEM) detection

[0041] The samples of exosome 1 and exosome 2 were dropped onto the copper grid respectively, and after drying, they were negatively stained with phosphotungstic acid. The morphology and size of the exosomes were observed under a transmission electron microscope. Figure 1 As shown, the exosomes 1 and 2 prepared by the present invention both have typical morphological characteristics and a double-layer membrane structure, with a particle size range of 50 to 150 nm, and are mainly concentrated around 100 nm.

[0042] 2.2 Nanoparticle Tracking Analysis (NTA)

[0043] The particle size and concentration of the exosome suspension were determined using an NTA instrument. The average particle size of exosome 1 and exosome 2 was measured to be 100 nm, and the particle size range was 50 nm to 150 nm. This result is consistent with the typical particle size range of exosomes (30-150 nm), indicating that the sample is mainly composed of exosomes. The particle concentrations of exosome 1 and exosome 2 were 1.5×10^10particles / mL and 1.2×10^10particles / mL, respectively, indicating that the concentrations of exosome 1 and exosome 2 were both high, suitable for subsequent biological experiments and applications.

[0044] Example 3: Preparation of magnetic beads for screening

[0045] There is a document (LI X, XIE X, LIAN W, et al. Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model. Exp Mol Med. 2018; 50(4): 29) pointing out that exosomes from adipose stem cells overexpressing Nrf2 can promote the proliferation of endothelial progenitor cells and reduce the expression of inflammatory proteins, thereby promoting the healing of foot wounds in diabetic rats. In addition, CD63 is a conventional exosome expression marker. Based on this, the present invention prepares a monoclonal antibody that specifically binds to Nrf2 protein and a monoclonal antibody that specifically binds to CD63 protein, and on this basis, prepares magnetic beads labeled with these two monoclonal antibodies for the sorting and enrichment of exosomes, thereby preparing a specific treatment study for wounds caused by diabetes.

[0046] according to Figure 2 The process (conventional preparation of monoclonal antibodies by mouse hybridoma cells) was followed, and mice were immunized multiple times with commercial recombinant human Nrf2 protein (ab132356) and recombinant human CD63 protein (ab316388), respectively. Through hybridoma cell screening and detection, a monoclonal antibody that specifically binds to Nrf2 protein and a monoclonal antibody that specifically binds to CD63 protein were finally prepared, wherein the monoclonal antibody that specifically binds to Nrf2 protein was designated as monoclonal antibody 1, and the monoclonal antibody that specifically binds to CD63 protein was designated as monoclonal antibody 2.

[0047] The above-mentioned monoclonal antibody 1 and monoclonal antibody variable region sequences were analyzed. The results showed that the amino acid sequences of the heavy chain variable region and the light chain variable region of monoclonal antibody 1 were shown in SEQ ID NO.1 and SEQ ID NO.2, respectively, and the amino acid sequences of the heavy chain variable region and the light chain variable region of monoclonal antibody 2 were shown in SEQ ID NO.3 and SEQ ID NO.4, respectively.

[0048] The prepared monoclonal antibody 1 and monoclonal antibody 2 were compared with the commercialized Anti-Nrf2 antibody (ab62352) and Anti-CD63 antibody (ab1318) using the direct ELISA method. The method is briefly described as follows: [Use coating buffer (50mM carbonate buffer, pH9.6) to dilute the recombinant human Nrf2 protein (ab132356) and recombinant human CD63 protein (ab316388) to 1μg / ml, respectively, and add them to the ELISA plate, 0.1ml per well, and coat overnight at 2-8℃. After washing with PBST three times, add 0.2ml of PBST buffer containing 1% BSA to each well and incubate at 37℃ for 2h. After washing with PBST three times, add the monoclonal antibody diluted with PBST buffer (adjust the concentration to 1ug / ml), mix well, and add them to the ELISA plate, 0.1ml per well, and incubate at 37℃ for 1h. After washing 3 times with PBST, add 0.1ml HRP-labeled goat anti-mouse IgG (or goat anti-rabbit) secondary antibody (1:5000 dilution) to each well; incubate at 37°C for 0.5h. After washing 3 times with PBST, add 0.1ml TMB colorimetric solution to each well and incubate at 37°C for 10min. Add 0.05ml stop solution (2M sulfuric acid) to each well, and detect OD450nm value immediately after termination. 】. The results show (Table 1) that the monoclonal antibody 1 and monoclonal antibody prepared by the present invention have good affinity and are suitable for the detection or capture of Nrf2 protein and CD63!

[0049] Table 1 Direct ELISA test results (OD450nm value)

[0050]

[0051] Take 5mg of carboxylated magnetic particles (purchased from JCR, with a diameter of 1μm), add 1ml of 0.1M MES buffer (pH6.0), vortex to mix, let stand on the magnetic stand for 5min to separate the magnetic particles from the liquid, discard the supernatant, add 1ml of TBST buffer, wash 3 times, then add 0.5ml MES pH 6.0 buffer, vortex. Add 0.1mg of monoclonal antibody 1 and monoclonal antibody 2 in equal proportions, vortex, and incubate at room temperature for 20min. Add 10μl of EDC with a concentration of 10mg / ml, vortex, and incubate at room temperature for 2h. After centrifugation, discard the supernatant, add 1ml of TBST buffer, and wash 3 times. Add 1ml of 50mMTris pH=8.0 buffer containing 1% BSA for blocking, and rotate and block at room temperature for 2h. After centrifugation, discard the supernatant, add 1ml of TBST buffer, and wash 3 times. Add 0.5 ml of 50 mM Tris pH=8.0 buffer containing 1% BSA to resuspend the magnetic particles, dilute to 0.5 mg / ml with 50 mM Tris pH=8.0 buffer containing 1% BSA, mix well after configuration, quantitatively divide into portions, and store in a dry place at 2-8°C.

[0052] Example 4: Study on the treatment of skin wounds induced by high glucose by exosomes

[0053] Fifteen clean-grade adult female SD rats (4-6 weeks old, weighing about 150-200 grams) were selected and induced after 2 weeks of adaptive feeding. They were fasted for 12 hours before induction, and then each rat was intraperitoneally injected with streptozotocin (100 mg / kg, 0.01M sodium citrate buffer, pH value of about 4.2-4.5) at a dose of 40-70 mg / kg. Blood glucose concentration and body weight were tested every day, and blood glucose levels were maintained between 16.7 and 33.3 mM by 6-18 units of insulin per day. After 4-6 weeks, after ether anesthesia, a single circular full-thickness skin wound was created on the skin of the hind dorsum of the diabetic rats using disposable 5 mm skin biopsy forceps and scissors for subsequent experiments.

[0054] Before the experiment, the size of the injured area on each rat's foot was measured, and the 15 rats were randomly divided into 3 groups (Table 2), with 5 rats in each group. The treatment study was carried out according to the drugs in Table 2. Observations and records were made on the 0th and 14th days of injection. The results showed that ( Figure 3 ), both group 1 and group 2 had good therapeutic effects (the lower the relative fibrosis, the better), but the therapeutic effect of group 2 was better than that of group 1.

[0055] Table 2 Drug groups and treatment methods

[0056]

[0057] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.

Claims

1. A magnetic bead for immunoaffinity capture of adipose-derived mesenchymal stem cell exosomes, characterized in that: The magnetic beads are coupled with monoclonal antibody 1 that specifically binds to Nrf2 protein and monoclonal antibody 2 that specifically binds to CD63 protein; wherein the amino acid sequences of the heavy chain variable region and the light chain variable region of monoclonal antibody 1 are shown in SEQ ID NO.1 and SEQ ID NO.2, respectively.

2. The magnetic bead according to claim 1, characterized in that The amino acid sequences of the heavy chain variable region and the light chain variable region of the monoclonal antibody 2 that specifically binds to the CD63 protein are shown in SEQ ID NO.3 and SEQ ID NO.4, respectively.

3. A method for preparing and purifying adipose-derived mesenchymal stem cell exosomes, characterized in that: The method comprises the following steps: (1) Adipose-derived stem cell culture, including adipose-derived stem cell recovery, adipose-derived stem cell subculture, and adipose-derived stem cell exosome-free culture medium treatment; (2) Isolation and purification of exosomes from adipose-derived stem cells, comprising: collecting the supernatant of adipose-derived stem cell culture, separating and purifying exosomes by ultracentrifugation, and purifying exosomes by immunoaffinity capture, wherein the immunoaffinity capture of purified exosomes is performed by using the magnetic beads prepared according to claim 1 to screen exosomes that highly express Nrf2 protein and CD63 protein from exosomes separated and purified by ultracentrifugation.

4. The method according to claim 3, characterized in that The collection of the adipose stem cell culture supernatant in step (2) comprises the following steps: collecting the cell culture supernatant after 24 hours of culture, centrifuging at 1000 rpm for 10 minutes to remove cell debris; passing the supernatant through a 0.22 μm filter membrane, transferring it to a 100KD ultrafiltration tube, and centrifuging it at 4°C 4000 rpm for 30 minutes to obtain a concentrated solution containing exosomes; centrifuging the concentrated solution containing exosomes at 4°C 10000 g for 30 minutes to further remove apoptotic bodies.

5. The method according to claim 3, characterized in that: The ultracentrifugation separation and purification of exosomes in step (2) The method comprises the following steps: transferring the exosome-containing concentrate prepared according to claim 4 into an ultracentrifuge tube, centrifuging at 100,000 g for 70 minutes at 4°C, and the precipitate is the exosome; carefully discarding the supernatant, resuspending the precipitate with an appropriate amount of PBS, and centrifuging at 100,000 g for 70 minutes; carefully discarding the supernatant, resuspending the precipitate with an appropriate amount of PBS, and then centrifuging at 100,000 g for 70 minutes to obtain the collected exosomes.

6. The method according to claim 3, characterized in that: The immunoaffinity capture and purification of exosomes in step (2) comprises the following steps: taking 1 ml of the collected exosomes prepared according to claim 5, adding it to 1 ml of the magnetic beads according to claim 1, and after being evenly mixed, rotating and incubating at room temperature for 1 hour to allow the antibody to fully bind to the exosomes; transferring the sample to a magnetic rack, separating the magnetic beads with antibodies, and aspirating the supernatant; using a washing buffer to wash the exosomes on the magnetic beads for 3 times; adding 1 ml of PBS buffer each time, rotating and mixing for 5 minutes, then using a magnetic rack to separate the magnetic beads, and discarding the supernatant; adding 0.2 ml of elution buffer, rotating and mixing for 5 minutes, repeating 3 times, collecting the eluate, and then dialyzing against PBS at 4°C overnight to obtain specific exosomes, and the obtained specific exosomes are filtered using 0.22 μm and stored at -80°C for later use.

7. Use of the monoclonal antibody 1 that specifically binds to the Nrf2 protein as claimed in claim 1 in the preparation of adipose-derived mesenchymal stem cell exosome immunoaffinity capture magnetic beads.

8. Use of the monoclonal antibody 2 that specifically binds to CD63 protein as claimed in claim 1 in the preparation of adipose-derived mesenchymal stem cell exosome immunoaffinity capture magnetic beads.

Citation Information

Patent Citations

  • Method for separating exosomes from serum by using immunomagnetic beads

    CN106289926A

  • Application of exosomes derived from human pluripotent stem cells

    CN109602766A

  • Exosome separation method based on CD63 antibody coupled magnetic beads

    CN114231523A

  • Application of mesenchymal stem cell exosome in preparation of reagent for improving pancreas islet function of diabetic patient

    CN117530959A

  • Separation and purification method and application of animal stem cell exosome

    CN117778309A